Profilo
Tracy Newbold formerly worked at United Therapeutics Corp., as Senior Director-Operations from 2011 to 2017, Atox Bio Ltd., as Senior Director-Clinical Operations from 2017 to 2020, Immunovant, Inc., as Senior Director-Clinical Operations in 2020, and Lexicon Pharmaceuticals, Inc., as Vice President-Clinical Operations.
Ms. Newbold received her undergraduate degree from The University of North Carolina at Chapel Hill.
Precedenti posizioni note di Tracy Newbold
| Società | Posizione | Fine |
|---|---|---|
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Corporate Officer/Principal | 01/01/2020 |
| UNITED THERAPEUTICS CORPORATION | Direttore operativo | 01/01/2017 |
| LEXICON PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
| IMMUNOVANT, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Tracy Newbold
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
















